Details of the Drug
General Information of Drug (ID: DMBZ60O)
Drug Name |
3-Imidazol-1-ylmethyl-1H-indole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL116794; 3-Imidazol-1-ylmethyl-1H-indole; 1H-Indole, 3-(1H-imidazol-1-ylmethyl)-; 19714-15-9; MLS000105265; AC1LGCIB; Cambridge id 5261471; CBDivE_013805; SCHEMBL9214699; 3-(imidazol-1-ylmethyl)indole; CTK0E0809; DTXSID40355147; FRADTKAUXQUOIJ-UHFFFAOYSA-N; MolPort-001-788-875; HMS2390H20; ZINC293947; 3-(imidazol-1-ylmethyl)-1H-indole; BDBM50022120; AKOS030489795; MCULE-1147695503; 3-(1H-imidazol-1-ylmethyl)-1H-Indole; BAS 01027138; 1-(1H-Indole-3-ylmethyl)-1H-imidazole
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 197.24 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||